Drug Patent Expirations for the Week of July 17, 2022

LEQVIO (inclisiran sodium) Novartis Patent: 10,590,418 Expiration: Jul 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…

The post Drug Patent Expirations for the Week of July 17, 2022 appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog